interesting blog post from April of this year ..

New Post Public Reply Private Reply Replies (1) Message Board
AlanC AlanC #185
interesting blog post from April of this year ..

specific to OTC et al

Best Brokers for Small Accounts:
1. Suretrader

I was going to rank the rest of my brokers beyond Suretrader, but there really isn't much point. Suretrader gets you around the Pattern Daytrader Rule, and that is a huge advantage. Costs can be a bit high, which is why it is important you make sure you reduce your commission rate. My number two choice would probably be Interactive Brokers, just because their platform costs and trade costs will be very low. Unfortunately you need to scrape together $10,000 to open an account with them, although you can withdraw most of the money as soon as the account is open. I'm sure there are plenty of other low-cost brokers out there with low account minimums, I just haven't tried them.

Best Brokers for Short Selling:
1. Centerpoint Securities
2. Suretrader
3. Interactive Brokers

If you want locates, these are the only brokers that will be able to get them for you. By far, Centerpoint has the best borrows - it isn't even close. Even if a stock isn't easy to borrow there at the start of the day, there are other ways to get a locate on it. If you want to short-sell pump and dumps, these are the only three brokers to consider.

Best Brokers for OTC Executions:
1. Centerpoint Securities
2. Regal Securities
3. Etrade
4. Speedtrader
5. Interactive Brokers

From what I remember and what I still hear, Suretrader has horrible executions, so they don't even make this list. Speedtrader has lost most of their OTC routes, and their NITE route functions terribly now as well, so they also have dropped quite far down the list. Centerpoint has the best executions, because they have the most OTC routes. They offer routing options to NITE, CSTI, ATDF, CDEL, ARCA, and a few others. Regal is a close second. They don't have quite as many routes, but they have a properly functioning NITE route as well as ARCA and CDEL options. While Etrade won't let you pick specific routes, there is little doubt in my mind that they have better executions than Speedtrader now. They also restrict trading on fewer stocks.

Best Brokers for Trading Cheap Stocks:
1. Regal Securities
2. Etrade
3. Speedtrader
4. Interactive Brokers

If you want to trade sub-penny stocks or anything even remotely cheap, you need a broker that won't eat you alive with routing fees and commissions. Suretrader and Centerpoint are not the brokers for this! Regal does not charge routing fees for most of their routes, so their superior executions earn them the #1 spot on this list. Interactive Brokers makes this list because their commission structure is .005/share OR 0.5% of total trade value, whichever is cheaper. At the end of the day, they will also be a cheaper option than Suretrader or Centerpoint.


so where are suretrader and centerpoint *located*

hmmmm


CenterPoint Securities Clearing
Clearing

CenterPoint Securities offers clearing options with Wedbush and ETC (Electronic Transaction Clearing). For more information on each, please click on the the website links below:


Wedbush Clearing


Electronic Transaction Clearing

CenterPoint Securities Order Routing
Order Routing

In equity trading, the method used to route orders is extremely important because of the potential for small price improvements and in many cases, being able to place the right kind of order during “fast market” periods. Since the equities market is made up of several “sub-markets” (ECN’s and Market Makers, lit and dark markets), a trader’s knowledge in the use of proper order routing to find the liquidity he or she needs to get the order executed is essential. While small price improvements may seemingly have little significance to a particular trade, price inefficiencies in order executions can collectively add up to a significant amount over a long period of time. This is obviously important for extremely active traders.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin's Path to $100,000: Expert Insights and Predictions

Updated Category News Views 115

Bitcoin's Potential Surge Towards $100,000 Crypto analyst Trader Mayne has recently suggested that Bitcoin could be preparing for one final push toward the impressive milestone of $100,000. He notes, however, that the overall market cycle resembles a prolonged five-year super cycle, which may culminate in a significant downturn in the near future. Current Market...

Continue Reading
Executive Leadership Shift at Geisinger with Dr. Mitchell

Updated Category News Views 755

Geisinger Appoints Jason W. Mitchell, M.D. as CMO In a notable leadership transition, Geisinger has officially announced the appointment of Jason W. Mitchell, M.D. as its executive vice president and chief medical officer. This decision comes after an exhaustive search aimed at finding a leader with the vision and expertise to guide the organization into its next chapter....

Continue Reading
What Investors Should Expect from Euroseas Earnings Release

Updated Category News Views 131

Insights Ahead of Euroseas's Earnings Report Euroseas (NASDAQ:ESEA) is gearing up to unveil its latest quarterly earnings, a moment that investors eagerly anticipate. This report holds substantial importance, as it can influence both investor sentiment and stock performance significantly. What Analysts Are Predicting Leading up to the earnings announcement, analysts...

Continue Reading
Establishing Strategic Ties: AEGGIS Summit Focus on Growth

Updated Category News Views 237

Atlantic Council and Antenna Group Unite for AEGGIS The Atlantic Council and Antenna Group have unveiled an exciting initiative known as the Alliance for Europe–Gulf Geopolitics & Investments Summit (AEGGIS). This summit is poised to play a pivotal role in strengthening the economic connections between European and Gulf nations. A Platform for Engagement and Dialogue...

Continue Reading
China Pharma Closes $5M Offering: What Lies Ahead?

Updated Category News Views 14

China Pharma's $5 Million Secured: A Strategic Move? Tough out there in the pharma jungle, isn't it? China Pharma Holdings, Inc. (NYSE American: CPHI) just wrapped up a neat $5 million direct offering. With each of their 2.5 million shares going for two bucks a pop, they're setting sails in a tumultuous sea. Now, why does this matter? Well, cash moshes in the pharma pit...

Continue Reading